Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer
AACE Endocrinology and Diabetes · 2026-09 · 13 (5) · 819-823
DOI: 10.1016/j.aed.2026.06.001 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Zhanna Zavgorodneva und 1 weiteren Autor:innen. Beteiligte Einrichtung: SUNY Downstate Health Science University, Brooklyn, New York. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background/Objective: Severe hypercalcemia is commonly associated with malignancy and, less frequently, with excessive calcium and vitamin D intake. Management is particularly challenging in patients with underlying disorders of calcium homeostasis. We present a case highlighting the complexities of treating hypercalcemia following discontinuation of denosumab in a patient with malignancy and underlying familial hypocalcemia on long-term calcium supplementation. Case Report: A 70-year-old woman with metastatic breast cancer and underlying familial hypocalcemia on chronic calcium and active vitamin D supplementation presented with hypercalcemic crisis following discontinuation of long-term denosumab therapy. She was treated with intravenous hydration and 2 doses of calcitonin, which led to a rapid decline in serum calcium levels and subsequent profound hypocalcemia requiring reinitiation of supplementation. Shortly after discharge, she was readmitted with recurrent hypercalcemia, again treated with 1 dose of calcitonin, followed by recurrent hypocalcemia. She was ultimately stabilized with careful titration of calcium and active vitamin D therapy.
Discussion
This case highlights several important clinical considerations, including the patient's familial history, oncologic history, the underlying mechanisms contributing to abrupt shifts in calcium levels, and strategies for effective management.
Conclusion
Treating hypercalcemia in patients with underlying hypocalcemia disorders can be challenging. Clinicians should take in consideration the complex pathophysiology of their disorder and monitor calcium closely to prevent hypocalcemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SUNY Downstate Health Science University, Brooklyn, New York.
- Division of Endocrinology, Department of Medicine, Maimonides Medical Center, Brooklyn, New York.
Zitieren
APA
Zavgorodneva, Z., & Karam, J. (2026). Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer. AACE Endocrinology and Diabetes, 13(5), 819-823. https://doi.org/10.1016/j.aed.2026.06.001
Vancouver
Zavgorodneva Z, Karam J. Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer. AACE Endocrinology and Diabetes. 2026;13(5):819-823. doi:10.1016/j.aed.2026.06.001
BibTeX
@article{Zavgorodneva2026,
author = {Zavgorodneva, Zhanna and Karam, Jocelyne},
title = {Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
volume = {13},
number = {5},
pages = {819--823},
doi = {10.1016/j.aed.2026.06.001}
}
EUVIMED